Kalbe Farma Future Growth
Future criteria checks 1/6
Kalbe Farma is forecast to grow earnings and revenue by 9.6% and 7.1% per annum respectively. EPS is expected to grow by 9% per annum. Return on equity is forecast to be 14.9% in 3 years.
Key information
9.6%
Earnings growth rate
9.0%
EPS growth rate
Pharmaceuticals earnings growth | 16.9% |
Revenue growth rate | 7.1% |
Future return on equity | 14.9% |
Analyst coverage | Good |
Last updated | 20 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 37,656,505 | 3,812,432 | 2,318,821 | 3,691,464 | 12 |
12/31/2025 | 34,913,466 | 3,491,398 | 2,125,511 | 3,385,518 | 14 |
12/31/2024 | 32,603,753 | 3,167,617 | 2,700,377 | 3,288,797 | 14 |
9/30/2024 | 32,126,890 | 3,080,202 | 3,586,588 | 4,956,052 | N/A |
6/30/2024 | 31,598,456 | 3,042,847 | 3,361,619 | 4,743,477 | N/A |
3/31/2024 | 30,943,002 | 2,868,591 | 2,604,666 | 3,914,467 | N/A |
12/31/2023 | 30,449,134 | 2,766,748 | 1,747,483 | 2,907,475 | N/A |
9/30/2023 | 30,312,738 | 2,961,621 | 1,171,758 | 2,172,143 | N/A |
6/30/2023 | 30,237,846 | 3,274,258 | 494,336 | 1,474,180 | N/A |
3/31/2023 | 29,786,958 | 3,403,045 | 240,749 | 1,135,214 | N/A |
12/31/2022 | 28,933,503 | 3,382,210 | 421,107 | 1,271,889 | N/A |
9/30/2022 | 28,344,270 | 3,381,401 | 313,176 | 1,099,074 | N/A |
6/30/2022 | 27,765,354 | 3,323,285 | 1,692,938 | 2,364,331 | N/A |
3/31/2022 | 27,261,485 | 3,302,038 | 2,005,220 | 2,696,856 | N/A |
12/31/2021 | 26,261,195 | 3,183,621 | 1,833,191 | 2,825,946 | N/A |
9/30/2021 | 25,115,512 | 2,993,591 | 2,996,737 | 4,002,944 | N/A |
6/30/2021 | 23,878,570 | 2,843,018 | 2,400,178 | 3,479,716 | N/A |
3/31/2021 | 23,332,456 | 2,780,456 | 2,813,800 | 3,965,497 | N/A |
12/31/2020 | 23,112,655 | 2,733,260 | 3,145,947 | 4,221,550 | N/A |
9/30/2020 | 22,902,507 | 2,618,701 | 2,045,808 | 3,469,847 | N/A |
6/30/2020 | 23,059,326 | 2,636,125 | 1,457,616 | 3,152,554 | N/A |
3/31/2020 | 23,063,580 | 2,580,962 | 987,889 | 2,903,915 | N/A |
12/31/2019 | 22,633,476 | 2,506,765 | 520,042 | 2,502,969 | N/A |
9/30/2019 | 22,222,813 | 2,568,165 | 650,143 | 2,414,095 | N/A |
6/30/2019 | 21,872,440 | 2,499,430 | 1,101,349 | 2,831,599 | N/A |
3/31/2019 | 21,424,910 | 2,462,761 | 1,074,438 | 2,634,606 | N/A |
12/31/2018 | 21,074,306 | 2,457,129 | 1,397,745 | 2,770,776 | N/A |
9/30/2018 | 20,770,524 | 2,428,630 | 1,065,101 | 2,533,889 | N/A |
6/30/2018 | 20,496,345 | 2,403,213 | N/A | 2,106,264 | N/A |
3/31/2018 | 20,298,678 | 2,404,792 | N/A | 2,108,688 | N/A |
12/31/2017 | 20,182,120 | 2,403,606 | N/A | 2,008,317 | N/A |
9/30/2017 | 20,087,979 | 2,376,474 | N/A | 1,957,670 | N/A |
6/30/2017 | 19,884,741 | 2,369,779 | N/A | 2,082,448 | N/A |
3/31/2017 | 19,722,837 | 2,324,750 | N/A | 2,233,931 | N/A |
12/31/2016 | 19,374,231 | 2,299,735 | N/A | 2,159,833 | N/A |
9/30/2016 | 19,135,808 | 2,207,683 | N/A | 2,402,394 | N/A |
6/30/2016 | 18,723,481 | 2,087,332 | N/A | 2,349,076 | N/A |
3/31/2016 | 18,190,514 | 2,038,815 | N/A | 2,171,154 | N/A |
12/31/2015 | 17,887,464 | 2,004,237 | N/A | 2,427,642 | N/A |
9/30/2015 | 17,737,870 | 2,078,487 | N/A | 2,277,535 | N/A |
6/30/2015 | 17,708,558 | 2,136,225 | N/A | 2,314,557 | N/A |
3/31/2015 | 17,548,723 | 2,101,577 | N/A | 2,504,167 | N/A |
12/31/2014 | 17,368,533 | 2,066,022 | N/A | 2,316,126 | N/A |
9/30/2014 | 17,320,906 | 2,040,142 | N/A | 1,863,426 | N/A |
6/30/2014 | 16,960,755 | 1,990,437 | N/A | 1,436,411 | N/A |
3/31/2014 | 16,578,629 | 1,968,549 | N/A | 1,092,379 | N/A |
12/31/2013 | 16,002,131 | 1,919,508 | N/A | 927,164 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: KLBF's forecast earnings growth (9.6% per year) is above the savings rate (6.8%).
Earnings vs Market: KLBF's earnings (9.6% per year) are forecast to grow slower than the ID market (19% per year).
High Growth Earnings: KLBF's earnings are forecast to grow, but not significantly.
Revenue vs Market: KLBF's revenue (7.1% per year) is forecast to grow slower than the ID market (9.7% per year).
High Growth Revenue: KLBF's revenue (7.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: KLBF's Return on Equity is forecast to be low in 3 years time (14.9%).